Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy

Author： Reardon David   Desjardins Annick   Peters Katherine   Gururangan Sridharan   Sampson John   Rich Jeremy   McLendon Roger   Herndon James   Marcello Jennifer   Threatt Stevie   Friedman Allan   Vredenburgh James   Friedman Henry  

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.103, Iss.2, 2011-06, pp. : 371-379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Large volume reirradiation as salvage therapy for glioblastoma after progression on bevacizumab

By Magnuson William   Ian Robins H.   Mohindra Pranshu   Howard Steven  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 133-139

Springer Publishing Company

Access to resources Recommend Favorite

Recurrent spinal cord glioblastoma: salvage therapy with bevacizumab

By Chamberlain Marc   Johnston Sandra  

Journal of Neuro-Oncology, Vol. 102, Iss. 3, 2011-05 ,pp. : 427-432

Springer Publishing Company

Access to resources Recommend Favorite

A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy

By Møller Søren   Grunnet Kirsten   Hansen Steinbjørn   Schultz Henrik   Holmberg Mats   Sorensen Morten   Poulsen Hans S.   Lassen Ulrik  

Acta Oncologica, Vol. 51, Iss. 6, 2012-07 ,pp. : 797-804

Informa Healthcare

Access to resources Recommend Favorite

Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer

By Komatsu Yoshito   Yuki Satoshi   Sogabe Susumu   Fukushima Hiraku   Nakatsumi Hiroshi   Kobayashi Yoshimitsu   Iwanaga Ichiro   Nakamura Michio   Hatanaka Kazuteru   Miyagishima Takuto   Kudo Mineo   Munakata Masaki   Meguro Takashi   Tateyama Miki   Sakata Yuh  

Acta Oncologica, Vol. 51, Iss. 7, 2012-09 ,pp. : 867-872

Informa Healthcare

Access to resources Recommend Favorite

Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: A multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma

By Ellingson Benjamin M.   Kim Eunhee   Woodworth Davis C.   Marques Helga   Boxerman Jerrold L.   Safriel Yair   McKinstry Robert C.   Bokstein Felix   Jain Rajan   Chi T. Linda   Sorensen A. Gregory   Gilbert Mark R.   Barboriak Daniel P.  

International Journal of Oncology, Vol. 46, Iss. 5, 2015-05 ,pp. : 1883-1892

Spandidos Publications

Access to resources Recommend Favorite